Study Sheds Light on Human Metapneumovirus in Outpatients

New research highlights the clinical differences between HMPV and other respiratory illnesses as vaccines become available for more prominent viruses.

Mar. 11, 2026 at 4:09am

Got story updates? Submit your updates here. ›

A recent study published in Open Forum Infectious Diseases analyzed acute respiratory illness (ARI) cases over five influenza seasons, providing new insights into the impact of human metapneumovirus (HMPV). The research found that HMPV peaks later in the season than influenza, a crucial difference for clinicians trying to differentiate between the viruses. As effective vaccines become available for respiratory syncytial virus (RSV) and influenza, HMPV may become a relatively more significant cause of illness, underscoring the need to better understand its unique characteristics.

Why it matters

The emergence of effective vaccines for RSV and influenza underscores the need to better understand HMPV. As protection against these viruses increases, HMPV may become a relatively more significant cause of respiratory illness. Understanding the unique characteristics of HMPV is therefore becoming increasingly important for public health planning.

The details

The study, based on data from the Pittsburgh site of the CDC-funded US Flu VE Network study, analyzed ARI cases over five influenza seasons. Patients included were at least six months old and experiencing a new or worsening cough for less than seven days. One key finding was that HMPV peaks later in the season than influenza, a crucial difference for clinicians trying to differentiate between the viruses.

  • The study analyzed data from the 2016-17 to 2019-20, and 2021-22 influenza seasons.

The players

US Flu VE Network

A CDC-funded network that conducts research on the effectiveness of influenza vaccines.

Open Forum Infectious Diseases

A peer-reviewed medical journal that published the study on HMPV.

Got photos? Submit your photos here. ›

What’s next

As we move forward, several trends are likely to shape the future of HMPV. Increased awareness among healthcare professionals will lead to more accurate diagnoses. Improved surveillance systems will provide a clearer picture of the virus's global circulation and seasonality. And, potentially, research into HMPV-specific vaccines or treatments may gain momentum.

The takeaway

This case highlights the growing importance of understanding HMPV as a significant respiratory virus, especially as vaccines become available for more prominent viruses like influenza and RSV. Accurate diagnosis and improved surveillance will be crucial in addressing the impact of HMPV on public health.